re: + + my favourite biotechs + + UPDATE:
1. CST: Expecting Patent Approvals from the FDA and Japan; Posters say these are overdue:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=113028#311493
2. MBP: Current trial to finish in Sept and results in Nov:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=52191&sym=MBP#130595
Date: 20 Sept: "A shareholder update detailing key trial milestones and reporting dates, together with recent developments, will be released to the market within the next week".
3. EPT: Interesting stock with Announcement(s) on the Topical formulation due in coming weeks:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=61463&sym=EPT#156349
AGM: 1 Oct
4. PGL: Waiting for developments: discussions with PHARMA:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=104816#287956
It will be interesting to know if discussions with a Pharma will be concluded before the AGM on 30 Nov. (Last year, the AGM was on 31 Oct.)
5. SLT: Since its agreement with the Burnet Institute on 23 Jan. 2003, has achieved much over that short period:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=124179#348504
Has just delivered its half year report. Waiting for Announcements re HEP A and C.
6. PXS: Two reports from trials due this month:
http://www.pharmaxis.com.au/
I accord the following urgency ratings: items 2, 6, 5, 1, 3-4. (That rating assists me with deciding what additional money to invest in what selections).
Gerry
Holds shares in items 1-6 incl.
Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.
Further info about individual stocks can be obtained by clicking on the "Search" button: Top left.
- Forums
- ASX - By Stock
- ASX
- + my favourite biotechs +
+ my favourite biotechs +, page-19
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$63.84 |
Change
-0.070(0.11%) |
Mkt cap ! $12.37B |
Open | High | Low | Value | Volume |
$63.88 | $63.92 | $62.85 | $12.79M | 201.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14 | $63.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$63.86 | 2974 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14 | 63.560 |
1 | 13 | 63.540 |
1 | 1109 | 63.520 |
2 | 1123 | 63.480 |
1 | 344 | 63.460 |
Price($) | Vol. | No. |
---|---|---|
63.900 | 512 | 1 |
63.920 | 929 | 1 |
64.000 | 667 | 6 |
64.050 | 300 | 1 |
64.100 | 578 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
ASX (ASX) Chart |